Clinical trial
Safety and Immunogenicity Study of the Recombinant Hepatitis E Vaccine(Escherichia Coli) Coadministration With Recombinant Hepatitis B Vaccine
NCT02584543 is registered in ClinicalTrials.gov with Xiamen Innovax Biotech Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Immunogenicity Study of the Recombinant Hepatitis E Vaccine(Escherichia Coli) Coadministration With Recombinant Hepatitis B Vaccine
- Lead sponsor
- Xiamen Innovax Biotech Co., Ltd
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 31, 2015
- Completion date
- August 25, 2016
- Enrollment
- 602 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.